Best Medical Oncologists for Immunotherapy in Mumbai, India

This page lists 7 immunotherapy doctors in Mumbai, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.

Quick answer

This page lists 7 immunotherapy doctors in Mumbai, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.

About Immunotherapy doctors in Mumbai, India

This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.

Immunotherapy doctors

Image not available Featured

Dr. Akshay Shah

MBBS, DNB, Fellowship in Stem Cell Transplantation
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Gleneagles Global Hospitals Mumbai, India22+ Years experience
Why consider this doctor?
  • 22+ years of experience in Medical Oncologist
  • Senior Consultant — Medical Oncology, Gleneagles Global Hospitals, Mumbai — Present
  • Specialist in Hematology and Bone Marrow Transplantation, Gleneagles Hospitals Parel, Mumbai
Expertise & Procedures
  • Allogeneic and Autologous Stem Cell Transplantation
  • Bone Marrow Aspiration and Biopsy
  • Intrathecal Chemotherapy Injections
  • Lumbar Puncture (Spinal Tap)
  • Pleurodesis
View all procedures →
Medical Oncologist Experience: 22+ YearsHospital Affiliation: Gleneagles Global HospitalsHospital accreditation: NABH, JCI
Image not available

Dr. Jeyhan B. Dhabhar

MBBS, MD, DrNB
Consultant — Medical Oncology · Specialty: Medical Oncologist
Wockhardt Hospital Mumbai, India5+ Years experience
Why consider this doctor?
  • 5+ years of experience in Medical Oncologist
  • Consultant — Medical Oncology, Wockhardt Hospital South Mumbai, Mumbai, India (Present)
  • Clinical Oncologist with expertise in precision medicine and personalized cancer treatment protocols
Expertise & Procedures
  • Systemic Chemotherapy Administration
  • Targeted Molecular Therapy
  • Cancer Immunotherapy
  • Hormone Therapy for Gynecologic Malignancies
  • Precision Medicine Treatment Planning
View all procedures →
Medical Oncologist Experience: 5+ YearsHospital Affiliation: Wockhardt HospitalHospital accreditation: NABH, JCI
Image not available

Dr. Jeyhan Dhabhar

MBBS, MD, DNB
Consultant — Medical Oncology and Hemato-Oncology · Specialty: Medical Oncologist and Hemato-Oncologist
Gleneagles Hospital, Mumbai Mumbai, India7+ Years experience
Why consider this doctor?
  • 7+ years of experience in Medical Oncologist and Hemato-Oncologist
  • Consultant Medical Oncologist and Hemato-Oncologist, Gleneagles Hospital, Mumbai, Parel — Present
  • Specialization in Precision Oncology and Cancer Genomics at Gleneagles Hospital, Mumbai — Present
Expertise & Procedures
  • Chemotherapy Administration and Management
  • Targeted Therapy Planning and Delivery
  • Cancer Immunotherapy
  • Hormone Therapy for Breast Cancer
  • Hormone Therapy for Prostate Cancer
View all procedures →
Medical Oncologist and Hemato-Oncologist Experience: 7+ YearsHospital Affiliation: Gleneagles Hospital, MumbaiHospital accreditation: NABH, JCI
Image not available

Dr. Jimmy Mirani

MBBS, MD, MCH
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Gleneagles Hospital Mumbai, India15+ Years experience
Why consider this doctor?
  • 15+ years of experience in Medical Oncologist
  • Senior Consultant, Medical Oncology — Gleneagles Hospital, Mumbai, Parel — Present
  • Medical Oncologist — Tata Memorial Hospital, Mumbai — Training and clinical practice
Expertise & Procedures
  • Chemotherapy Administration and Management
  • Cancer Immunotherapy and Checkpoint Inhibitors
  • Targeted Molecular Therapy for Cancer
  • Hormone Therapy for Breast and Prostate Cancer
  • Bone Marrow Transplantation and Stem Cell Therapy
View all procedures →
Medical Oncologist Experience: 15+ YearsHospital Affiliation: Gleneagles HospitalHospital accreditation: NABH, JCI
Image not available

Dr. Jyoti Bajpai

MBBS, MD, DM, Fellowship in Pediatric Oncology, ESMO Certification
Senior Consultant — Medical Oncology and Hemato-Oncology · Specialty: Medical Oncologist and Hemato-Oncologist
Apollo Hospitals Mumbai, India22+ Years experience
Why consider this doctor?
  • 22+ years of experience in Medical Oncologist and Hemato-Oncologist
  • Senior Consultant, Medical Oncology and Hemato-Oncology, Apollo Hospitals, Navi Mumbai, India — Present
  • Fellowship in Pediatric Oncology, Tata Memorial Centre, Mumbai, India
Expertise & Procedures
  • Chemotherapy administration for solid tumors
  • Immunotherapy and checkpoint inhibitor therapy
  • Targeted molecular therapy
  • Hormone therapy for breast cancer
  • Neoadjuvant chemotherapy protocols
View all procedures →
Medical Oncologist and Hemato-Oncologist Experience: 22+ YearsHospital Affiliation: Apollo HospitalsHospital accreditation: JCI, NABH
Image not available

Dr. Rohit Ramesh Pai

MBBS, MD in Internal Medicine, DM in Medical Oncology, MRCP (UK), MRCP (SCE), DNB in Medical Oncology
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Gleneagles Hospital Mumbai, India10+ Years experience
Why consider this doctor?
  • 10+ years of experience in Medical Oncologist
  • Senior Consultant — Medical Oncology, Gleneagles Hospital, Mumbai
  • Consultant Medical Oncologist, Bombay Hospital, Mumbai
Expertise & Procedures
  • Chemotherapy Administration and Management
  • Cancer Immunotherapy Planning and Delivery
  • Targeted Therapy Selection and Monitoring
  • Hormone Therapy for Breast Cancer
  • Hormone Therapy for Prostate Cancer
View all procedures →
Medical Oncologist Experience: 10+ YearsHospital Affiliation: Gleneagles HospitalHospital accreditation: NABH, JCI
Image not available

Dr. Viraj Nevrekar

DM in Medical Oncology, MD in Medicine, ECMO Certification
Senior Consultant — Medical Oncology & Bone Marrow Transplant · Specialty: Medical Oncologist & Hemato-Oncologist
Gleneagles Global Hospitals Mumbai, India11+ Years experience
Why consider this doctor?
  • 11+ years of experience in Medical Oncologist & Hemato-Oncologist
  • Senior Consultant — Medical Oncology & Bone Marrow Transplant, Gleneagles Global Hospitals, Mumbai, Parel
  • Over 11 years of clinical practice in medical oncology and hemato-oncology across leading Indian hospital networks
Expertise & Procedures
  • Allogeneic Bone Marrow Transplantation
  • Autologous Stem Cell Transplantation
  • High-dose Chemotherapy Regimens
  • Cancer Immunotherapy and CAR-T Cell Therapy
  • Targeted Molecular Therapy for Solid Tumors
View all procedures →
Medical Oncologist & Hemato-Oncologist Experience: 11+ YearsHospital Affiliation: Gleneagles Global HospitalsHospital accreditation: NABH, JCI

Hospitals where these doctors practise

Gleneagles Global Hospitals (Global Hospitals)🇮🇳 Parel, Mumbai, India
Starting from$1,000

Gleneagles Global Hospitals (Global Hospitals)

Est. 1996
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditationJCIJoint Commission International accreditation
ImmunotherapyMedical OncologyLiver TransplantCardiac Surgery
5+
Doctors for Immunotherapy
4.6
183 reviews
450+
Beds
30+
Years Since Founded
Dr. Akshay ShahDr. Jeyhan DhabharDr. Jimmy Mirani
+2 more
Wockhardt Hospital🇮🇳 Mumbai, India
Starting from$1,000

Wockhardt Hospital

Est. 2014
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditationJCIJoint Commission International accreditation
ImmunotherapyMedical OncologyCardiac SurgeryCardiology
1+
Doctors for Immunotherapy
4.4
30 reviews
350+
Beds
12+
Years Since Founded
Dr. Jeyhan B. Dhabhar

Why consider treatment in India?

Many international patients consider India for lymphoma treatment for several reasons, including:

More affordable estimates

Competitive indicative costs compared with many other countries, for similar clinical standards.

Internationally accredited hospitals

Hospitals experienced in treating international patients.

Experienced specialists

Doctors who regularly manage similar cases.

Care coordination support

A team to help with planning, medical translation and follow-up.

About the Procedure

What is Immunotherapy?

Immunotherapy uses drugs that help the patient's own immune system recognize and destroy cancer cells, and is used across many cancers including breast, lung, colorectal, gastric/esophageal, liver/pancreatic, ovarian/gynaecological, head & neck cancers, leukemia, lymphoma, and multiple myeloma. It is given as an infusion in cycles, either alone or combined with chemotherapy/targeted therapy, and India offers globally approved immunotherapy drugs and advanced options like CAR-T cell therapy at a fraction of Western costs. Treatment plans are individualized based on tumor type, biomarker status (e.g., PD-L1, MSI), and stage of disease.

Who may be considered?

Immunotherapy may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.

How does it work?

Drugs such as PD-1/PD-L1 and CTLA-4 inhibitors are given as IV infusions every 2-4 weeks to block signals that let cancer cells evade the immune system, often combined with chemotherapy for greater effect.

3 approaches available for this procedure:

Immune Checkpoint Inhibitor Therapy

Most Common

Drugs such as PD-1/PD-L1 and CTLA-4 inhibitors are given as IV infusions every 2-4 weeks to block signals that let cancer cells evade the immune system, often combined with chemotherapy for greater effect.

Comprehensive Investigations

Estimated cost: $400 - $1,500

CBC, liver and kidney function tests, thyroid function tests, PD-L1/MSI/biomarker testing, contrast CT/PET-CT, ECG, tumor board review

Treatment / Procedure Estimate

Estimated cost in India: $1,500 - $3,500 per cycle

Stay in India

Pre-procedure stay (outside hospital): ~2-3 days
Hospitalisation: ~1 day (day-care per cycle)
Recovery period (outside hospital): ~2-3 days recommended between cycles
Total stay: approx 4-6 cycles over 3-6 months

Usually Included in Hospital Package

  • Oncologist consultations
  • Day-care infusion facility
  • Drug administration and monitoring
  • Pre-cycle blood work
  • Nursing care during infusion

Usually Not Included

  • Cost of immunotherapy drug (billed per cycle)
  • Interim PET-CT/imaging for response assessment
  • Management of immune-related side effects if hospitalization needed
  • Genetic/biomarker testing not covered under package

Recovery and follow-up

Most patients tolerate immunotherapy infusions as outpatients and can resume light activity within a day or two, though fatigue, skin rash, or flu-like symptoms are common and are monitored through regular blood tests before each cycle. CAR-T patients require a longer inpatient recovery period with close monitoring for delayed immune reactions.

Risks

Immunotherapy can trigger immune-related side effects affecting the skin, gut, lungs, liver, or endocrine glands, and rarely severe reactions like cytokine release syndrome (especially with CAR-T) that require prompt hospital management. Response to treatment varies by tumor type and biomarker status, and not all patients achieve remission.

Alternatives

Depending on the cancer type and stage, alternatives include conventional chemotherapy, targeted therapy, radiation therapy, hormonal therapy, surgery, or a combination approach as advised by the tumor board.

What we need to prepare a formal estimate

Share whatever you have — the care team will confirm the final checklist after reviewing your case.

Reports required

  • Histopathology and biopsy report confirming cancer type
  • Biomarker/genetic testing results (PD-L1, HER2, MSI, EGFR, etc.)
  • Recent CT/PET-CT/MRI imaging reports
  • Complete blood count and liver/kidney function tests
  • Previous chemotherapy/radiotherapy/surgery records
  • Bone marrow biopsy report (for blood cancers)
  • Cardiac evaluation report (ECG/ECHO)
  • Discharge summaries from previous hospitalizations

Patient information needed

  • Current age, weight, and general performance status
  • Detailed cancer diagnosis with stage and biomarker status
  • History of prior treatments and response to them
  • Any known drug allergies or autoimmune conditions
  • Current medications including steroids or immunosuppressants
  • Presence of other chronic conditions (diabetes, heart or lung disease)
  • Availability of a caregiver/attendant during treatment
  • Preferred treatment start date and travel flexibility

Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.

Want a formal estimate?

Share your reports and patient information so our care coordination team can review your case.

How this directory is built

Doctors are matched using the specialty, location, condition (Immunotherapy) and procedure (Immunotherapy) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.

Need help with the next step?

Share your needs with our care coordination team for information about doctors and hospitals.

Common questions

FAQs about Immunotherapy in Mumbai, India

What is Lymphoma?
Lymphoma is a type of blood cancer that originates in lymphocytes, the immune cells that travel through the lymphatic system. It can arise in lymph nodes, the spleen, bone marrow, or virtually any organ, and encompasses a wide spectrum of subtypes ranging from slow-growing (indolent) to highly aggressive forms.
What are the symptoms and health risks of Lymphoma?
Common signs include painless swelling of lymph nodes in the neck, armpits, or groin; persistent fatigue; unexplained weight loss; drenching night sweats; and fever — a cluster sometimes referred to clinically as 'B symptoms.' Some people also experience shortness of breath, itching, or a feeling of fullness in the abdomen if the spleen or abdominal nodes are involved. These symptoms can overlap with many other conditions, and their presence alone is not sufficient to establish a diagnosis of lymphoma.
How is Lymphoma diagnosed?
Diagnosis typically begins with a clinical evaluation, blood tests (including a full blood count, LDH, and beta-2 microglobulin levels), and imaging such as CT or PET-CT scanning to assess the extent of disease. A biopsy of an affected lymph node or tissue — analysed with immunohistochemistry and, where indicated, molecular or genetic testing — is essential to confirm the specific lymphoma subtype. Staging (using systems such as the Ann Arbor or Lugano classification) and relevant prognostic indices (such as the International Prognostic Index for non-Hodgkin lymphoma) then guide treatment planning.
How is Lymphoma treated?
Treatment is highly individualised and depends on the lymphoma subtype, stage, patient age, overall health, and specific molecular features. Options range from active surveillance ('watch and wait') for certain slow-growing indolent lymphomas to chemotherapy, immunotherapy, targeted therapy, radiation therapy, or combinations of these for more aggressive or advanced disease. In eligible patients with relapsed or refractory lymphoma, high-dose chemotherapy followed by autologous stem cell transplantation — or, in selected cases, allogeneic transplantation — may offer the best chance of sustained remission.
Can Lymphoma be treated without a procedure?
The majority of lymphoma treatment is non-surgical. Indolent lymphomas that are asymptomatic and low-burden may be managed initially with active monitoring alone. When treatment is needed, chemotherapy regimens (such as R-CHOP for many B-cell lymphomas), monoclonal antibody immunotherapy, targeted small-molecule agents, and radiotherapy are the primary tools, and many patients achieve remission without any surgical intervention.
When is Immunotherapy considered for Lymphoma?
Immunotherapy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Lymphoma?
Lymphoma is typically evaluated and managed by a medical oncologist or haematologist with specific expertise in lymphoid malignancies, often in close collaboration with a radiation oncologist when radiotherapy is part of the plan, and with a bone marrow transplant specialist if stem cell transplantation is being considered.
How do I choose a doctor for Lymphoma?
When selecting a care team, look for a specialist with documented experience in the specific lymphoma subtype relevant to your case, access to a multidisciplinary tumour board, and affiliation with a centre that offers the full range of therapies — including advanced options such as stem cell transplantation and clinical trials — along with structured long-term follow-up.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.